Serum Institute seeks Covovax inclusion in COVID vaccination program Ruchika Sharma30 Jun 2022 1:00 PM IST“Even employees of our firm, who have relentlessly worked on this life-saving vaccine, are requesting to us to provide this life-saving vaccine for...
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 11:29 AM ISTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
SEC to review Serum Institute qHPV vaccine trial data today Ruchika Sharma15 Jun 2022 11:20 AM ISTNew Delhi: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 10:00 AM ISTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
Vaccine maker SII to set up first manufacturing plant in Africa Ruchika Sharma25 May 2022 11:15 AM ISTAsked about possible investments, Poonawalla said such projects typically required at least around $300 million.
SII chief Dr Cyrus S Poonawalla conferred Dean's Medal by Johns Hopkins Bloomberg School of Public Health Ruchika Sharma24 May 2022 1:15 PM ISTDr. Poonawalla was also conferred with the Padma Bhushan Award by Hon'ble President of India, Shri Ram Nath Kovind at Rashtrapati Bhavan on 21st...
Serum Institute seeks CDSCO permission for Phase-3 trial of Covovax as booster dose in children aged 2-18 Ruchika Sharma24 May 2022 12:03 PM ISTThe study will evaluate the immunogenicity and safety of the vaccine as a booster dose in comparison with the placebo.
SII to seek DCGI market nod for qHPV vaccine against cervical cancer Dr. Nandita Mohan16 May 2022 5:26 PM ISTThe Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human...
Serum Institute to seek DCGI market nod for qHPV vaccine against cervical cancer Ruchika Sharma16 May 2022 11:26 AM ISTAn official source aware of the development said if the government approves the SII's proposal, then it will save a significant amount of time to...
SII, Symbiosis ink pact to set up vaccine research centre Ruchika Sharma14 May 2022 11:23 AM ISTSymbiosis International University's faculty of health sciences dean Rajiv Yeravdekar said the initiative will help not only in addressing futuristic...
Serum Institute of India gets DCGI nod for skin test kit for latent TB diagnosis Ruchika Sharma12 May 2022 12:44 PM ISTPune-based firm Mylab has partnered with the SII for this kit, an official source said.
